nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Analysis of gastric-type mucinous carcinoma of the uterine cervix — An aggressive tumor with a poor prognosis: A multi-institutional study
|
Nishio, Shin |
|
2019 |
153 |
1 |
p. 13-19 |
artikel |
2 |
A novel PI3K/mTOR dual inhibitor, CMG002, overcomes the chemoresistance in ovarian cancer
|
Choi, Hye Joung |
|
2019 |
153 |
1 |
p. 135-148 |
artikel |
3 |
A patient-centered mobile health application to motivate use of genetic counseling among women with ovarian cancer: A pilot randomized controlled trial
|
Vogel, Rachel I. |
|
2019 |
153 |
1 |
p. 100-107 |
artikel |
4 |
Apatinib exerts anti-tumour effects on ovarian cancer cells
|
Ding, Jing |
|
2019 |
153 |
1 |
p. 165-174 |
artikel |
5 |
Association between body mass index and surgical menopausal symptoms in patients with early stage endometrial cancer
|
Cripe, James C. |
|
2019 |
153 |
1 |
p. 123-126 |
artikel |
6 |
Association of chemotherapy and radiotherapy sequence with overall survival in locoregionally advanced endometrial cancer
|
Goodman, Chelain R. |
|
2019 |
153 |
1 |
p. 41-48 |
artikel |
7 |
53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer
|
Hurley, Rachel M. |
|
2019 |
153 |
1 |
p. 127-134 |
artikel |
8 |
Breastfeeding factors and risk of epithelial ovarian cancer
|
Modugno, Francesmary |
|
2019 |
153 |
1 |
p. 116-122 |
artikel |
9 |
Cisplatin and radiation therapy in HIV-positive women with locally advanced cervical cancer in sub-Saharan Africa: A phase II study of the AIDS malignancy consortium
|
Einstein, Mark H. |
|
2019 |
153 |
1 |
p. 20-25 |
artikel |
10 |
Clinical significance of genotyping for human papillomavirus (HPV) 16 18/45 combined with cytology in cervical exfoliated cells in HPV oncogenic mRNA-positive women
|
Wang, Jiajian |
|
2019 |
153 |
1 |
p. 34-40 |
artikel |
11 |
Comparison of survival outcomes between minimally invasive surgery and conventional open surgery for radical hysterectomy as primary treatment in patients with stage IB1–IIA2 cervical cancer
|
Kim, Se Ik |
|
2019 |
153 |
1 |
p. 3-12 |
artikel |
12 |
Cost-effectiveness evaluation of HPV self-testing offered to non-attendees in cervical cancer screening in Switzerland
|
Vassilakos, Pierre |
|
2019 |
153 |
1 |
p. 92-99 |
artikel |
13 |
Cytokine-induced memory-like natural killer cells have enhanced function, proliferation, and in vivo expansion against ovarian cancer cells
|
Uppendahl, Locke D. |
|
2019 |
153 |
1 |
p. 149-157 |
artikel |
14 |
Disparities in gynecologic cancer genetics evaluation
|
Hinchcliff, Emily M. |
|
2019 |
153 |
1 |
p. 184-191 |
artikel |
15 |
Editorial Board
|
|
|
2019 |
153 |
1 |
p. iv |
artikel |
16 |
En bloc pelvic resection for ovarian carcinomatosis: Hudson procedure in 10 steps
|
Angeles, Martina Aida |
|
2019 |
153 |
1 |
p. 209-210 |
artikel |
17 |
Endocrine therapy in endometrial cancer: An old dog with new tricks
|
Jerzak, Katarzyna J. |
|
2019 |
153 |
1 |
p. 175-183 |
artikel |
18 |
Frailty in ovarian cancer identified the need for increased postoperative care requirements following cytoreductive surgery
|
Yao, TingTing |
|
2019 |
153 |
1 |
p. 68-73 |
artikel |
19 |
Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2 mutations; a systematic review of risks and benefits
|
Gordhandas, Sushmita |
|
2019 |
153 |
1 |
p. 192-200 |
artikel |
20 |
Implicit bias toward cervical cancer: Provider and training differences
|
Liang, Juliana |
|
2019 |
153 |
1 |
p. 80-86 |
artikel |
21 |
Infection, thrombosis, and oncologic outcome after interval debulking surgery: Does perioperative blood transfusion matter?
|
Manning-Geist, Beryl L. |
|
2019 |
153 |
1 |
p. 63-67 |
artikel |
22 |
Modified panel-based genetic counseling for ovarian cancer susceptibility: A randomized non-inferiority study
|
McCuaig, Jeanna M. |
|
2019 |
153 |
1 |
p. 108-115 |
artikel |
23 |
Pelvic lymphadenectomy by vaginal natural orifice transluminal endoscopic surgery (vNOTES) for early-stage endometrial cancer
|
Oh, Soo Hyun |
|
2019 |
153 |
1 |
p. 211-212 |
artikel |
24 |
PI3K oncogenic mutations mediate resistance to afatinib in HER2/neu overexpressing gynecological cancers
|
Bonazzoli, Elena |
|
2019 |
153 |
1 |
p. 158-164 |
artikel |
25 |
Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology
|
Stoler, Mark H. |
|
2019 |
153 |
1 |
p. 26-33 |
artikel |
26 |
Targeted surgical prevention of epithelial ovarian cancer is cost effective and saves money in BRCA mutation carrying family members of women with epithelial ovarian cancer. A Canadian model
|
Hoskins, Paul |
|
2019 |
153 |
1 |
p. 87-91 |
artikel |
27 |
The application of fibrin sealant for the prevention of lymphocele after lymphadenectomy in patients with gynecological malignancies: A systematic review and meta-analysis of randomized controlled trials
|
Prodromidou, Anastasia |
|
2019 |
153 |
1 |
p. 201-208 |
artikel |
28 |
The association between progesterone receptor expression and survival in women with adult granulosa cell tumors
|
Puechl, Allison M. |
|
2019 |
153 |
1 |
p. 74-79 |
artikel |
29 |
The change in landscape after a new landmark is constructed: Radical hysterectomy for early cervical cancer and Minimally Invasive Surgery
|
Leitao Jr, Mario M. |
|
2019 |
153 |
1 |
p. 1-2 |
artikel |
30 |
Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer
|
Yang, Bingyi |
|
2019 |
153 |
1 |
p. 55-62 |
artikel |
31 |
Unexpected malignant uterine pathology: Incidence, characteristics and outcome in a large single-center series of hysterectomies for presumed benign uterine disease
|
Wagner, P. |
|
2019 |
153 |
1 |
p. 49-54 |
artikel |